Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2018

Katz LM, Hielscher T, Liechty B, Silverman J, Zagzag D, Sen R, et al. Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol. 2018;135(6):955-963.

Sederdahl BK, Yi J, Jerris RC, Gillespie SE, Westblade LF, Kraft CS, et al. Trends in rotavirus from 2001 to 2015 in two paediatric hospitals in Atlanta, Georgia. Epidemiol Infect. 2018;146(4):465-467.

Gordon JK, Martyanov V, Franks JM, Bernstein EJ, Szymonifka J, Magro C, et al. Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial. Arthritis Rheumatol. 2018;70(2):308-316.

DeSimone RA, Nowak MD, Lo DT, Crowley KM, Parra P, Cushing MM, et al. Logistical and safety implications of temperature-based acceptance of returned red blood cell units. Transfusion. 2018;58(6):1500-1505.

Goel R, Chappidi MR, Patel EU, Ness PM, Cushing MM, Frank SM, et al. Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014. JAMA. 2018;319(8):825-827.

Goyal A, Zhang G, Yang B. Differential expression patterns of GATA3 in usual and differentiated types of vulvar intraepithelial neoplasia: potential diagnostic implications. Mod Pathol. 2018;31(7):1131-1140.

Ko H-, Berk M, Chung Y-, Willard B, Bareja R, Rubin M, et al. Loss of an Androgen-Inactivating and Isoform-Specific HSD17B4 Splice Form Enables Emergence of Castration-Resistant Prostate Cancer. Cell Rep. 2018;22(3):809-819.

Jacobs SE, Zhong E, Hartono C, Satlin MJ, Magro CM, Jenkins SG, et al. The Brief Case: Disseminated Mycobacterium haemophilum Infection in a Kidney Transplant Recipient. J Clin Microbiol. 2018;56(1).

Morrone KA, Pecker LH, Rand J, Davila J, Oyeku S, Little JA, et al. Association of silent infarcts in sickle cell anemia with decreased annexin A5 resistance. Blood Cells Mol Dis. 2018;69:53-56.

Cheng S, Inghirami G, Cheng S, Tam W. Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL. J Hematol Oncol. 2018;11(1):105.